Navigating the challenges of NT-proBNP result disclosure in clinical research. [PDF]
Kent DA +4 more
europepmc +1 more source
Regulatory bodies must critically assess their role in the wellness wave of supplement marketing. [PDF]
Marcon AR.
europepmc +1 more source
Critical Care Cardiology Fellowship Training in China: Past, Present, and Future. [PDF]
Liu WJ, Luo Z, Luo MH, Tu GW.
europepmc +1 more source
Reply of the Authors: Safety and pharmacology of AMY109, a long-acting anti-interleukin-8 antibody, for endometriosis: a double-blind, randomized phase 1 trial. [PDF]
Wang PH +5 more
europepmc +1 more source
Safety and efficacy of a feed additive consisting of <i>Lactococcus lactis</i>DSM 34262 as an acidity regulator additive for all animal species (Lactosan GmbH & Co.KG). [PDF]
EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP) +23 more
europepmc +1 more source
Safety and efficacy of a feed additive consisting of <i>Lactiplantibacillus plantarum</i> DSM 34271 as an acidity regulator additive for all animal species (Lactosan GmbH & Co.KG). [PDF]
EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP) +23 more
europepmc +1 more source
Safety evaluation of the food enzyme protein-glutamine γ-glutamyltransferase from the genetically modified <i>Bacillus licheniformis</i> strain NZYM-TR. [PDF]
EFSA Panel on Food Enzymes (FEZ) +17 more
europepmc +1 more source
Safety and efficacy of a feed additive consisting of <i>Pediococcus pentosaceus</i>NCIMB 12674 for all animal species (Danstar Ferment AG). [PDF]
EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP) +21 more
europepmc +1 more source

